<p>週三早晨，隨着最新消息傳出 <strong>唐納德·特朗普</strong> 總統即將簽署行政命令，將大麻從 第一類藥物重新分類為第三類藥物。</p>
<ul>
<li><em>CGC 股票正在上漲。</em> 查看此處的圖表和價格走勢。</li>
</ul>
<p>這一消息在大麻行業引發了一波樂觀情緒，投資者期待與第三類藥物相關的長期財務解放：即取消國税局第 280E 條款。</p>
<p><strong>接下來閲讀：</strong> 埃隆·馬斯克準備進行 SpaceX IPO，估值超過 RTX、波音和洛克希德的總和</p>
<h2>税收減免</h2>
<p>税法第 280E 條款 禁止 企業從與第一類或第二類物質的販運相關的收入中扣除其他已確立的商業費用。</p>
<p>多年來，280E 條款使美國的大麻經營者陷入困境，阻止他們扣除標準商業費用，導致有效税率往往超過 70%。</p>
<p>將大麻重新分類為較低的分類，例如第三類藥物，將解除 280E 的負擔，可能使許多大麻企業首次實現盈利。</p>
<p>“這絕對是一個遊戲規則的改變，”<strong>博里斯·喬丹</strong>，<strong>Curaleaf Holdings</strong> 的執行董事長，在 2024 年告訴《華爾街日報》。</p>
<p>“這是我們等待了近 10 年的事情，” 喬丹補充道。</p>
<p>然而，專家警告稱，第三類藥物並不等於完全合法化。</p>
<p>儘管這一舉措將緩解研究限制和税收負擔，但並不會自動消除聯邦對娛樂用途的刑事處罰。</p>
<p>事實上，大麻在聯邦法律下仍然是非法的，並且與許多已合法化大麻的州法律之間的衝突仍然存在。</p>
<h2>市場反應</h2>
<p>大麻股票在高於平均水平的交易量下波動，並在社交媒體上引發熱議，投資者在等待特朗普總統的正式聲明。</p>
<p>投資者可以通過 AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) 以及加拿大重量級公司的個股，如 <strong>Tilray Brands, Inc.</strong> (NASDAQ: TLRY)、<strong>Canopy Growth Corp.</strong> (NASDAQ: CGC)、<strong>Aurora Cannabis Inc.</strong> (NASDAQ: ACB)、<strong>Cronos Group, Inc.</strong> (NASDAQ: CRON) 和 <strong>SNDL Inc.</strong> (NASDAQ: SNDL) 來監控該行業。</p>
<p><strong>接下來閲讀：</strong></p>
<ul>
<li>大資金押注特斯拉股票：億萬富翁的牛市與熊市在第三季度</li>
</ul>
<p><em>照片來源：Shutterstock</em></p>

極光大麻

TLRY

SNDL

CRON

<p>大麻股票上漲，因為有報道稱特朗普總統可能將大麻重新分類為第三類藥物，這可能會減輕國税局第 280E 條款的負擔。這一變化可能允許大麻企業扣除標準費用並實現盈利。然而，第三類藥物並不意味着完全合法，聯邦刑事處罰仍將存在。投資者正密切關注該行業，Tilray、Canopy Growth、Aurora Cannabis、Cronos Group 和 SNDL 等股票的交易活動有所增加</p>

<p>Cannabis stocks rallied Wednesday morning following fresh reports that President <strong>Donald Trump</strong> is poised to sign an executive order rescheduling marijuana from Schedule I to Schedule III.</p>
<div class="lb-trans"><p>週三早晨，隨着最新消息傳出 <strong>唐納德·特朗普</strong> 總統即將簽署行政命令，將大麻從 第一類藥物重新分類為第三類藥物。</p>
</div><ul>
<li><em>CGC stock is climbing.</em> See the chart and price action here.</li>
</ul>
<div class="lb-trans"><ul>
<li><em>CGC 股票正在上漲。</em> 查看此處的圖表和價格走勢。</li>
</ul>
</div><p>The news sent a wave of optimism through the cannabis sector as investors anticipated long-awaited financial liberation associated with Schedule III: the removal of IRS Section 280E.</p>
<div class="lb-trans"><p>這一消息在大麻行業引發了一波樂觀情緒，投資者期待與第三類藥物相關的長期財務解放：即取消國税局第 280E 條款。</p>
</div><p><strong>Read Next:</strong> Elon Musk Prepares SpaceX IPO Valued At More Than RTX, Boeing, Lockheed Combined</p>
<div class="lb-trans"><p><strong>接下來閲讀：</strong> 埃隆·馬斯克準備進行 SpaceX IPO，估值超過 RTX、波音和洛克希德的總和</p>
</div><h2>Tax Relief</h2>
<div class="lb-trans"><h2>税收減免</h2>
</div><p>Section 280E of the tax code prohibits businesses from deducting otherwise established business expenses from income associated with the trafficking of Schedule I or II substances.</p>
<div class="lb-trans"><p>税法第 280E 條款 禁止 企業從與第一類或第二類物質的販運相關的收入中扣除其他已確立的商業費用。</p>
</div><p>For years, 280E has crippled U.S. cannabis operators by preventing them from deducting standard business expenses, resulting in effective tax rates often exceeding 70%.</p>
<div class="lb-trans"><p>多年來，280E 條款使美國的大麻經營者陷入困境，阻止他們扣除標準商業費用，導致有效税率往往超過 70%。</p>
</div><p>Rescheduling cannabis to a lower classification, such as Schedule III, would lift the 280E burden, potentially allowing many cannabis businesses to become profitable for the first time.</p>
<div class="lb-trans"><p>將大麻重新分類為較低的分類，例如第三類藥物，將解除 280E 的負擔，可能使許多大麻企業首次實現盈利。</p>
</div><p>&#34;It's an absolute game-changer,&#34; <strong>Boris Jordan</strong>, executive chairman of <strong>Curaleaf Holdings</strong>, told the Wall Street Journal in 2024.</p>
<div class="lb-trans"><p>“這絕對是一個遊戲規則的改變，”<strong>博里斯·喬丹</strong>，<strong>Curaleaf Holdings</strong> 的執行董事長，在 2024 年告訴《華爾街日報》。</p>
</div><p>&#34;It's something we've been waiting for, for the better part of 10 years,&#34; Jordan added.</p>
<div class="lb-trans"><p>“這是我們等待了近 10 年的事情，” 喬丹補充道。</p>
</div><p>However, experts caution that Schedule III is not full legalization.</p>
<div class="lb-trans"><p>然而，專家警告稱，第三類藥物並不等於完全合法化。</p>
</div><p>Though the move would ease research restrictions and tax burdens, it does not automatically erase federal criminal penalties for recreational use.</p>
<div class="lb-trans"><p>儘管這一舉措將緩解研究限制和税收負擔，但並不會自動消除聯邦對娛樂用途的刑事處罰。</p>
</div><p>In fact, marijuana would still remain illegal under federal law, and the conflict with many state laws that have legalized cannabis will still exist.</p>
<div class="lb-trans"><p>事實上，大麻在聯邦法律下仍然是非法的，並且與許多已合法化大麻的州法律之間的衝突仍然存在。</p>
</div><h2>Market Reaction</h2>
<div class="lb-trans"><h2>市場反應</h2>
</div><p>Cannabis stocks were moving on above-average trading volumes and trending across social media as investors awaited an official statement from President Trump.</p>
<div class="lb-trans"><p>大麻股票在高於平均水平的交易量下波動，並在社交媒體上引發熱議，投資者在等待特朗普總統的正式聲明。</p>
</div><p>Investors can monitor the sector through the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) and the individual stocks of Canadian heavyweights like <strong>Tilray Brands, Inc.</strong> (NASDAQ: TLRY), <strong>Canopy Growth Corp.</strong> (NASDAQ: CGC), <strong>Aurora Cannabis Inc.</strong> (NASDAQ: ACB), <strong>Cronos Group, Inc,</strong> (NASDAQ: CRON), and <strong>SNDL Inc.</strong> (NASDAQ: SNDL).</p>
<div class="lb-trans"><p>投資者可以通過 AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) 以及加拿大重量級公司的個股，如 <strong>Tilray Brands, Inc.</strong> (NASDAQ: TLRY)、<strong>Canopy Growth Corp.</strong> (NASDAQ: CGC)、<strong>Aurora Cannabis Inc.</strong> (NASDAQ: ACB)、<strong>Cronos Group, Inc.</strong> (NASDAQ: CRON) 和 <strong>SNDL Inc.</strong> (NASDAQ: SNDL) 來監控該行業。</p>
</div><p><strong>Read Next:</strong></p>
<div class="lb-trans"><p><strong>接下來閲讀：</strong></p>
</div><ul>
<li>Big Money Bets On Tesla Stock: Billionaire Bulls and Bears In Q3</li>
</ul>
<div class="lb-trans"><ul>
<li>大資金押注特斯拉股票：億萬富翁的牛市與熊市在第三季度</li>
</ul>
</div><p><em>Photo: Shutterstock</em></p>
<div class="lb-trans"><p><em>照片來源：Shutterstock</em></p>
</div>

高期望：隨着特朗普考慮重新調整，大麻股票炙手可熱